Abstract:Background Thyroid metastases from colorectal cancer (CRC) are rare, both in clinical practice and in the literature; hence, their diagnosis, appropriate treatment, and prognostic factors require further investigations. Methods A retrospective analysis was performed for four cases of thyroid metastases from CRC, treated in our center between January 2005 and December 2015, and the relevant literature was searched using PubMed, resulting in the identification of 17 patients with detailed information available. The clinical data and follow-up information of our patients and the previously reported cases were collected and compared. Results The median age of the 21 patients was 59 years (44.5 and 66 years for our patients and the previously reported cases, respectively). Fifteen (71.4%) primary tumors were distributed throughout the distal colon or rectum (75% [3/4] in our center and 70.5% [12/17] in the previously reported cases). According to our analysis, we found that 81.0% of patients (17/21) showed concomitant lung metastasis. Among them, all four patients in our center showed lung metastasis, and 75% (3/4) developed thyroid metastases after the lung metastasis. In the previously reported cases, the corresponding proportions were 76.5 and 76.5% (13/17) of patients, respectively. The median time after primary tumor diagnosis to thyroid metastasis development was 28 months (26 months in our center and 35 months in the previously reported cases). One patient with advanced CRC in our center died 5 months after the thyroid metastasis was identified, while the remaining three patients are currently alive (longest follow-up time, 27 months). The median survival time after thyroid metastasis during 3 years of follow-up of the previously reported 17 patients was 12 months. There was no difference in the overall survival between patients treated non-surgically (8/21) and patients undergoing thyroidectomy alone or thyroidectomy with adjuvant therapy (13/21) ( p = 0.388). In addition, we found that the overall survival of the patients whose other metastases were treated with radical treatment was superior to that in those treated with palliative treatment ( p = 0.022). Conclusions Thyroid metastases from CRC are rare in clinical practice and are a manifestation of advanced CRC. The prognosis of patients with thyroid metastases from CRC is related to various factors, including the grade of malignancy of the primary lesion, the presence of other metastases, and whether the metastases are timely diagnosed and a radical treatment strategy is employed.

Management of Solitary Intracranial Metastases of Differentiated Thyroid Carcinoma: 11 Pathologically Confirmed Cases and Systematic Literature Review

Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literature

Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years

Surgical treatment of 21 patients with spinal metastases of differentiated thyroid cancer.

Brain Metastases in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis, and Management

Prognostic Factors for Differentiated Thyroid Carcinoma and Review of the Literature

Clinical Outcomes and Prognostic Factors in Patients with No Less Than Three Distant Organ System Metastases from Differentiated Thyroid Carcinoma.

Brain Metastases from Thyroid Carcinoma: Prognostic Factors and Outcomes

Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer after Total Thyroidectomy and Radioactive Iodine Therapy

Pulmonary Metastases in Differentiated Thyroid Cancer: Efficacy of Radioiodine Therapy and Prognostic Factors.

Differentiated Microcarcinoma of the Thyroid Gland in 45 Cases

The Surgical Management of Intracranial Metastasis Secondary to Follicular Cell‐Derived Thyroid Carcinoma

Uncommon Metastases from Differentiated Thyroid Carcinoma.

Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer

Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care ‐ A systematic review

Improved Survival after Primary Tumor Resection in Distant Metastasis Medullary Thyroid Carcinoma: a Population-Based Cohort Study with Propensity Score Matching

Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma

Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review

Comparative Study of Single-Center Patients with Thyroid Metastases from Colorectal Cancer and Previously Reported Cases in the Literature.

Surgery for metastatic spinal differentiated thyroid cancer: feasibility, outcome, and prognostic factors

A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)